GL-0810

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGL-0810
Drug Alias NameGL-0810
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGliknik Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Maryland, Baltimore
Active IndicationsN/A
Inactive IndicationsSquamous Cell Carcinoma of Head and Neck

Other Information

ATC CodeN/A
Related LinksN/A